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Abstract 
Rationale: Animal studies suggest that the pineal hormone melatonin influences basal stress 
hormone levels and dampens hormone reactivity to stress. Objectives: We investigated 
whether melatonin also has a suppressive effect on stress-induced catecholamine and cortisol 
release in humans. As stress hormones affect memory processing, we further examined a 
possible accompanying modulation of memory function. Methods: Fifty healthy young men 
received a single oral dose of either 3mg melatonin (n = 27) or placebo medication (n = 23). 
One hour later, they were exposed to a standardized psychosocial laboratory stressor (Trier 
Social Stress Test). During stress, subjects encoded objects distributed in the test room, for 
which memory was assessed a day later (“memory encoding under stress”). 15 min following 
stress, memory retrieval for words learnt the day before was tested (“memory retrieval after 
stress”). Plasma epinephrine and norepinephrine levels, salivary free cortisol levels, and 
psychological responses (attention, wakefulness) were repeatedly measured before and after 
stress exposure. Results: Melatonin specifically enhanced recognition memory accuracy of 
objects encoded under stress (p <.001). In contrast, 15 min after stress, when cortisol levels 
were highest, retrieval of memories acquired the day before was not influenced by melatonin. 
Moreover, melatonin did not influence stress-induced elevation of catecholamine and cortisol 
levels which in turn did not correlate with the effects of melatonin on memory. Conclusions: 
The findings point to a primary action of melatonin on central nervous stimulus processing 
under conditions of stress, and possibly on memory consolidation, and exclude any 
substantial suppressive action of the substance on hormonal stress responses. 
 
Key words: Melatonin; memory; recognition; stress; cortisol; norepinephrine; epinephrine 
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Introduction 
Acute stress activates the sympathetic nervous system (SNS) and the hypothalamic-
pituitary-adrenal (HPA) axis, leading to heightened levels of catecholamines (epinephrine 
and norepinephrine) and glucocorticoids (cortisol in primates, corticosterone in rodents) 
(Mason 1986, Kirschbaum 1993).  
Besides the regulation of circadian rhythms and sleep (Brzezinski 1997; Cajochen et 
al. 2003), the pineal hormone melatonin has been found to directly modulate catecholamine 
and cortisol levels. In rodents, exogenously administered melatonin decreases 
norepinephrine and epinphrine levels (Girouard et al. 2003; K-Laflamme et al. 1998; 
Viswanathan et al. 1986; Wang et al. 1999). Although not uniform, in young human 
subjects, placebo-controlled studies revealed decreased plasma levels of norepinephrine but 
not of epinephrine within 60- 90 minutes after oral intake of 1 or 2mg melatonin (Arangino 
et al. 1999; Cagnacci et al. 1998; Nishiyama et al. 2001). In contrast, effects of melatonin 
on cortisol/corticosterone levels are less consistent. In young humans, single or repeated 
administration of melatonin did not affect basal or pharmacologically stimulated cortisol 
secretion (Cagnacci et al. 1995; Forsling et al. 1999; Pawlikowski et al. 2002; Perras et al. 
2005; Seabra et al. 2000; Waldhauser et al. 1987; Wright et al. 1986), whereas in rats and 
primates the corresponding glucocorticoid measures were found to be decreased after 
melatonin (Konakchieva et al. 1997; 1998; Torres-Farfan et al. 2003). Notably, besides 
lowering basal corticosterone concentrations, in rats melatonin also attenuated 
corticosterone reactivity to an acute or chronic stressor (Konakchieva et al. 1997). Here we 
aimed to examine whether melatonin likewise attenuates cortisol as well as catecholamine 
reactivity to an acute stressor in humans. 
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Because the stress hormones of interest here, epinephrine, norepinephrine, and 
cortisol influence encoding, consolidation and retrieval of memories (Roozendaal et al. 
2006), a second aim of our study was to examine whether a modulation of the stress 
response by melatonin would be accompanied by changes in memory processing.  
In rodents and humans, increased levels of epinephrine and norepinephrine improve 
memory formation (Cahill and Alkire 2003; McGaugh and Roozendaal 2002; O'Carroll et 
al. 1999; Southwick et al. 2002), while blockade of the beta-adrenergic system inhibits 
memory formation (Cahill et al. 1994; van Stegeren et al. 1998). Furthermore, acute 
glucocorticoid administration or stress-induced endogenous glucocorticoid release 
specifically affect different memory phases in rodents and humans. As such, 
glucocorticoids dose-dependently enhance memory encoding and consolidation 
(Abercrombie et al. 2003; Beckner et al. 2006; de Kloet et al. 1999; Roozendaal 2000; 
Roozendaal et al. 2006), but distinctly impair memory retrieval (Buchanan et al. 2006; de 
Quervain et al. 1998; de Quervain et al. 2000; Domes et al. 2005). We expected that a 
dampening effect of melatonin on the hormonal stress response is accompanied by reduced 
encoding under stress (due to suppressed catecholamine and cortisol levels), but improved 
retrieval of memories (due to suppressed cortisol levels).  
 
 
Methods 
Participants 
The study is part of a larger project investigating effects of melatonin administration 
on psychobiological stress reactivity (Wirtz et al. 2008). The study sample consisted of fifty 
healthy, medication-free, non-smoking men (20-35 years). Subjects with any acute or chronic 
somatic or psychiatric disorders were excluded. Additional exclusion criteria, as obtained by 
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subjects’ self-report, included regular strenuous exercise, smoking, alcohol and illicit drug 
abuse, heart disease, elevated blood sugar and diabetes, elevated cholesterol, liver and renal 
diseases, chronic obstructive pulmonary disease, allergies and atopic diathesis, rheumatic 
diseases, current infectious diseases, and insufficient knowledge of the German language. If 
the personal history was not conclusive, the subjects’ primary care physician was contacted 
for clarification. The Ethics Committee of the State of Zürich, Switzerland, formally 
approved the research protocol. All participants provided written informed consent before 
participating and received 100 Swiss francs after participation. 
 
Design and procedure 
A placebo-controlled, single-blind, between-subjects design was used, with 27 men 
recruited for the 'melatonin' group and 23 men in the placebo group. Raw data coding and 
analysis was conducted by an independent person blind to the drug condition. Participants 
in both groups took part in three experimental sessions taking place on three consecutive 
days. They abstained from food and drinks (other than water) for two hours prior to 
experimental sessions and from beverages with caffeine or alcohol and physical activity, 
starting on the evening two days before the first experimental session. Participants 
maintained a regular sleep-wake rhythm the 3 nights before and during the study, with 
sleep between 10-11.30 pm and 7-8.30 am. 
Sessions started between 1 and 2 p.m., and for each participant always at the same 
time of day. On day 1, subjects were tested for normal cardiovascular functioning. After 
subjects had been sitting quietly for 20 minutes, heart rate and blood pressure were 
assessed by fully automated plethysmography (Omron 773, Mannheim, Germany). In the 
first session (day 1) subjects learned a list of words that was used for later testing memory 
retrieval under conditions of stress during the second session (day 2). In the second session 
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(day 2) hormonal responses to the Trier Social Stress Test (TSST) as well as memory under 
conditions of stress (“memory retrieval after stress”) were tested after subjects had received 
either placebo or melatonin (3 mg, orally, "Melatonin Standard" purchased from 
PhysioLogics, Northglenn, CO, 80234 USA). Drugs were administered 60 min before the 
TSST, based on the known kinetics of melatonin after oral intake of 1-5 mg indicating that 
at this time blood levels of melatonin reach maximum values that are maintained for at 
least 2-4 hours (Dollins et al. 1994; Waldhauser et al. 1984). The third session (day 3) 
served to test memory retrieval of items (objects distributed in the test room) that the 
subjects had encoded under conditions of stress (“memory encoding under stress”) on the 
second session on day 2. 
 
Psychosocial stress procedure and hormone measurements 
On the second session, 90 min after subjects had been prepared for blood sampling by 
insertion of an intravenous catheter, and 60 min after oral drug intake, stress was induced by 
the Trier Social Stress Test. We applied the standard procedure of the TSST, which combines 
a short introduction phase followed by a 5-min preparation phase, a 5-min mock job 
interview, and a 5-min mental arithmetic task in front of an unknown panel of one man and 
one woman. The TSST has repeatedly been found to induce profound endocrine and 
cardiovascular responses (Dickerson and Kemeny 2004; Kirschbaum et al. 1993).  
Before and after the TSST, saliva and blood was sampled repeatedly to determine the 
hormonal stress response. 
For assessment of free cortisol levels, saliva samples were collected immediately 
before (-1 min) and immediately after the TSST procedure (+1 min) as well as 10, 20, 30, 40, 
50, and 60 min after completion of the TSST using Salivette collection devices (Sarstedt, 
Rommelsdorf, Germany). Samples were stored at -20°C until analysis with a commercially 
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available competitive chemiluminescence immunoassay (LIA; IBL, Hamburg, Germany, 
sensitivity of 0.16 ng/ml). Intra- and inter-assay variability was less than 7.7 and 11.5%, 
respectively. 
 For assessment of plasma norepinephrine, epinephrine and melatonin levels, blood 
was sampled in EDTA-coated monovettes (Sarstedt, Numbrecht, Germany) immediately 
before (-1 min) and after the stressor (+1 min), as well as 10, 20, and 60 min after TSST 
completion. Blood was immediately centrifuged for 10 min at 2000 x g at 4°C; and plasma 
was stored at -80°C until analysis. Epinephrine and norepinephrine levels were determined by 
means of high-performance liquid chromatography (HPLC) and electrochemical detection 
after liquid–liquid extraction (Ehrenreich et al. 1997). Melatonin was extracted with 
methylene chloride and analysed with a reversed phase HPLC with fluorescence detection 
(Vieira et al. 1992). The lower limit of detection (LOD) for the melatonin concentration was 
2.5 pg/mL. Samples with a melatonin concentration below the LOD were set at half the LOD 
(i.e. 1.25 pg/ml) following previous recommendation for a skewed data set (Hornung and 
Reed 1990). Inter- and intra-assay coefficients of variation were < 10%.   
  
Testing of memory encoding under stress and memory retrieval after stress 
Memory encoding under stress. To examine the influence of melatonin on memory 
encoding under stress on day 2, 22 objects (e.g. a telephone, a glas, a bottle, a rubbish-bin) 
were placed in the TSST room. All objects were put in the subjects’ field of view. It was 
assured that subjects perceived all relevant objects during the TSST by instructing them to 
look around for a minute and to comment on the set up of the room at the transition from the 
speech to the mental arithmetic part of the TSST. On day 3, free recall and recognition of the 
objects were tested. For recognition memory, photos of the 22 objects were presented with 44 
similar objects as distractors.  
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Memory retrieval after stress. For assessment of the influence of melatonin on 
memory retrieval under heightened cortisol levels, on day 1 (one day prior to stress 
exposure) subjects were instructed to memorize 30 words (10 positive, 10 neutral, 10 
negative), which were presented in randomized order for 5 sec each (Kuhlmann et al. 
2005b). Immediately following the presentation, free recall of the words was tested. On day 
2, a surprise delayed free recall test and recognition test of the words learnt the day before 
were employed 15 minutes after cessation of the TSST, when cortisol levels peak. For the 
recognition test 60 distractor words matched to the target words for valence (20 positive, 20 
neutral, 20 negative) were included (Domes et al. 2004). To account for possible within and 
between subject variance in memory, free recall performance after stress was expressed as 
the percentage of words remembered in relation to the words remembered immediately 
after learning on the day before (Kuhlmann et al. 2005a; Kuhlmann et al. 2005b).  
Measures of recognition memory were determined according to the two-threshold 
model (Snodgrass and Corwin 1988), including hit rate (HR = proportion of old objects 
classified as “old”), false alarm rate (FAR= proportion of new objects classified as “old”), 
the memory accuracy measure Pr [= HR – FAR], and the response bias measure Br [= 
FAR/ (1-Pr)]. 
 
Assessment of attention, mood, and anxiety 
Influence of melatonin on attention, concentration, wakefulness and state anxiety were 
assessed before and after the stressor using the d2 letter cancellation test of attention (-65 
min; +35 min) (Brickenkamp 1994), the wakefulness-scale of the Multidimensional Mood 
Questionnaire (-80 min, -20 min, +20 min) (Steyerberg et al. 2001) and the state scale of the 
State-Trait-Anxiety-Inventory (STAI) (-85 min, -20 min, +5 min) (Spielberger et al. 1970). 
Baseline measures for attention, wakefulness and state anxiety were obtained before 
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melatonin or placebo administration. All questionnaires have been broadly used and shown 
satisfactory internal consistency and validity.  
 
Statistical analyses 
SPSS Inc. (Version 14.0) software packages (SPSS, Chicago, IL) was used for data 
analysis. Data are presented as mean ± SEM. All tests were two-sided and the level of 
significance was set at p < 0.05. Missing data were excluded listwise.  
To determine changes in hormone levels and psychological measures, two-way 
ANOVAs with repeated measures were calculated with group (melatonin vs. placebo) as 
between-subject factor and time as within-subject factor (repeated factor: 2 for attention, 3 for 
wakefulness and state anxiety, 5 for epinephrine and norepinephrine, 8 for cortisol). To 
account for effects of repeated measurements, we applied Huynh-Feldt corrections for 
repeated measures. We present corrected p-values but provide the original degrees of 
freedom without Huynh-Feldt-correction. Baseline hormonal levels as well as differences in 
memory performance between the two groups were examined by one-way ANOVAs. For 
stress hormones, areas under the total response curve with respect to ground (AUCg) were 
calculated with the trapezoid formula (Pruessner et al. 2003). In order to assess whether the 
stress hormones modulated the influence of melatonin on memory, respective hormone 
AUCg were introduced as covariates in the ANOVA.   
 
Results 
Group characteristics and melatonin levels 
Table 1 provides subjects' characteristics for the two groups of men treated with 3 mg 
melatonin (n = 27) and placebo (n = 23). There were no differences in age, BMI, heart rate, 
and blood pressure (all p>0.11). Also attention performance on the d2 test, state anxiety and 
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wakefulness before drug intake on day 2, as well as immediate free recall of words (measured 
on day 1) were comparable between groups (melatonin: hits 18.59 ± 0.93, false alarms 0.59 ± 
0.15; placebo: hits 19.00 ± 0.65, false alarms 0.52 ± 0.17) (all p’s>0.27). Measurement of 
melatonin in plasma samples 1 min prior to TSST exposure (day 2) confirmed higher plasma 
melatonin concentrations 60 minutes after substance intake in the melatonin group (421.8 ± 
113.9 pg/ml, versus 2.3 ± 0.4 pg/ml in the placebo group F(1, 48) = 12.00, p<0.001). 
 
Stress hormone levels at baseline and stress responses 
At baseline. Resting levels of cortisol (p=0.57), norepinephrine (p=0.22) and 
epinephrine (p=0.41) did not differ between groups.  
Stress responses. Results on catecholamine stress reactivity have been previously 
reported (Wirtz et al. 2008). The TSST induced strong increases in cortisol (F(7, 301) = 
29.1, p<0.001), norepinephrine (F(4, 176) = 66.9, p<0.001) and epinephrine levels (F(4, 
168) = 16.5, p <0.001) (Figure 1). Compared with placebo after melatonin, epinephrine 
levels were on average slightly higher and norephinephrine levels were on average slightly 
lower. However these differences did not reach any significance. The groups did neither 
significantly differ before and after stress (main effect of group) nor in response to stress 
(interaction group-by-time) in cortisol (p’s>0.47), norepinephrine (p’s>0.18), and 
epinephrine (p’s>0.14).  
 
Effects of melatonin on memory encoding under stress and memory retrieval after stress  
Memory encoding under stress. Recognition of objects that were encoded during 
TSST performance (day 2) was measured on day 3. Recognition testing revealed large 
differences between groups (Figure 2 summarizes results for hit rate, false alarm rate, 
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memory accuracy, response bias). Subjects in the melatonin group compared to the placebo 
group showed distinctly enhanced memory accuracy (Pr) (melatonin 0.32 ± 0.02 vs. placebo 
0.22 ± 0.04, F(1, 49) = 5.44, p<0.05) for objects encoded under stress exposure. An overall 
higher hit rate (melatonin 0.50 ± 0.02 vs. placebo 0.38 ± 0.02, F(1, 49) = 22.15, p<0.001) 
contributed to this effect. False alarm rate (p=0.58) and response bias (Br) (p=0.07) did not 
significantly differ between the groups. Free recall of objects did not reveal any significant 
difference between the melatonin (hits 6.52 ± 0.35, false alarms 0.48 ± 0.14) and placebo 
(hits 6.17 ± 0.33, false alarms 0.48 ± 0.17) groups (all p’s>0.48). 
Memory retrieval after stress. As to retrieval function under conditions of stress, 
melatonin did not influence free recall of words (15 min after stress on day 2) learned on day 
1 (main effect of treatment, p>0.49) (melatonin: hits 13.00 ± 0.87, false alarms 1.22 ± 0.29; 
placebo: hits 12.70 ± 0.72, false alarms 1.00 ± 0.27). Similarly, there was no influence of 
melatonin on the free recall of words depending on the valence (positive, neutral, negative) of 
the words (p>0.99, for valence by treatment interaction) (positive words: melatonin: hits 4.33 
± 0.31; placebo: hits 4.00 ± 0.31; neutral words: melatonin: hits 4.63 ± 0.42, placebo: hits 
4.48 ± 0.38; negative words: melatonin: hits 4.04 ± 0.38; placebo: hits 4.22 ± 0.36). 
Melatonin compared to placebo also had no influence on recognition measures of the words 
(melatonin: hits 21.48 ± 1.39, false alarms 4.04 ± 0.61; placebo: hits 23.43 ± 1.26, false 
alarms 3.61 ± 0.54), regardless of valence (all p’s > 0.22) (positive words: melatonin: hits 
7.72 ± 0.32; placebo: hits 8.27 ± 0.40; neutral words: melatonin: hits 8.04 ± 0.38, placebo: 
hits 8.45 ± 0.29; negative words: melatonin: hits 7.44 ± 0.30; placebo: hits 7.91 ± 0.29). 
 
Influence of stress hormones on melatonin memory effects 
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Since previous studies indicated strong influences of cortisol and catecholamines on 
encoding and retrieval of memories (de Quervain et al. 2000; McGaugh and Roozendaal 
2002), in supplementary analyses we controlled for the stress response of each of these 
hormones by entering the respective AUCg as covariate into memory ANOVAs. None of 
these ANCOVAs did reveal any significance for any hormonal covariate (all p’s>0.25) but 
confirmed the treatment effects reported above for the original analyses. 
 
Attention, wakefulness, mood and anxiety 
Attention significantly increased from before stress (-65 min) (melatonin 504.85 ± 
13.41, placebo 486.39 ± 15.49) to the time after stress (+35 min) (melatonin 538.93 ± 
12.10, placebo 525.57 ± 15.02) (F(1, 48) = 147.8, p<0.001), but did not differ between 
groups (all p’s>0.4). Wakefulness significantly decreased throughout the experiment (time 
effect: F(2, 94) = 14.36, p<0.001), with a stronger decrease in the melatonin group (group 
by time effect: F(2, 94) = 5.3, p<0.01) (-80 min: melatonin 16.08 ± 0.54, placebo 15.22 ± 
0.55; -20min: melatonin 13.26 ± 0.70, placebo 14.3 ± 0.64; +20min: melatonin 13.19 ± 
0.65, placebo 14.65 ± 0.68). Noteworthy, the decrease in wakefulness as well as the 
increase in attention entered as covariate did not significantly change the reported 
melatonin effects on memory.  
State anxiety significantly increased in both groups during anticipation of the 
psychosocial stressor (time effect: F(2, 86) = 42.38, p<0.001), but groups did not differ in 
their state anxiety response to the psychosocial stressor (p>0.69).  
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Discussion 
This is the first study to assess whether melatonin modulates hormonal stress 
reactivity in humans and whether this modulation would be accompanied by changes in 
memory processing. Oral administration of 3 mg melatonin did not substantially alter 
cortisol, epinephrine and norepinephrine responses to a psychosocial stressor. However, 
melatonin invoked distinct changes in memory function. Going beyond previous studies 
examining effects of melatonin on encoding/consolidation and retrieval processes in 
combination, here we aimed at clearly dissociating effects of melatonin on these two types of 
memory processes. The central finding of our study is that melatonin specifically improved 
memory for objects that were presented together with the stressor, as indicated by enhanced 
accuracy and hit rate at a recognition test for these objects a day later. In contrast, 15 min 
after stress, when cortisol levels were highly elevated, memory retrieval of words learned a 
day before remained unaffected by melatonin. Although we cannot demonstrate a cortisol-
induced impairment of memory retrieval in both groups due to an absent non-stressed control 
group (Kuhlmann et al. 2005b, Buchanan et al. 2006; Domes et al. 2004), stress hormonal 
responses did not influence melatonin-modulated effects on retrieval. The findings point to a 
primary action of melatonin on central nervous stimulus processing under conditions of 
stress, and exclude any substantial suppressive action of the substance on hormonal stress 
responses. 
 Notably, the melatonin-induced improvement of memory was revealed only in a 
recognition test, but not in free recall testing. Recognition is a most direct test of the 
strength of an association in memory, whereas free recall, in contrast to recognition 
memory, is characterized by the virtual absence of external memory cues at retrieval and 
thus is an indicator of how a memory is cross-linked to other associated memories that 
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could facilitate its accessibility (Lockhart 2000; Tulving 1970). On this background, the 
selective improvement of recognition performance strongly suggests that melatonin 
enhances associative strength, i.e., the signal-to-noise ratio at stimulus encoding under 
stress and possibly during consolidation. 
The present results of melatonin effects on memory  are difficult to integrate into 
results from the few previous studies investigating effects of melatonin on memory. First, 
most of these studies did not separately assess encoding and retrieval functions. Second, 
none of these studies tested memory function during stress, which per se affects memory 
encoding and retrieval  (de Quervain et al. 1998; Elzinga et al. 2005; Kuhlmann et al. 
2005b; Leeuwenberg et al. 1992). Concurring with the present observations, in adult male 
rats, melatonin facilitated social recognition (Argyriou et al. 1998), and in humans several 
studies failed to reveal effects of melatonin on memory using free recall procedures 
(Rutledge et al. 2004; Waldhauser et al. 1984; Wesensten et al. 2005). However, 
Lieberman et al. (1984) found no effect of 240 mg melatonin on both free recall as well as 
recognition memory of words. In that study both encoding and retrieval were measured at 
times of enhanced melatonin concentration, and the melatonin dose was distinctly higher, 
which may account for the divergent findings. However, even with the 3-mg dose of the 
present study, plasma levels exceeding the normal physiological range were reached, 
making a saturation of receptors likely. Interestingly, in a recent study (Gorfine et al. 
2007), subjects given 2 mg melatonin before a 2-hour retention interval between encoding 
and retrieval showed, similarly to subjects who napped during the retention interval, higher 
activation in the left parahippocampus at successful retrieval of word-pairs. This suggests 
that, in addition to the effect of encoding, melatonin can exert a sleep-like enhancing effect 
on consolidation of memories (Gorfine et al. 2007).  
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Consistent with numerous previous studies (Deacon and Arendt 1995; Dollins et al. 
1994; Nickelsen et al. 1989; Rutledge et al. 2004; Waldhauser et al. 1984; Wright et al. 
1986), melatonin compared to placebo decreased wakefulness. As this effect was not in 
relation to the memory effects of melatonin, wakefulness can be ruled out as a possible 
confound. Notably, the decrease in wakefulness also was not linked to changes in measures 
of attention and concentration. Performance on the d2 concentration test was closely 
comparable between the two treatment groups before and after the stressor. Indeed, the 
stressor caused a distinct increase in attention and concentration in both groups that 
possible overrode any effect of melatonin in the opposite direction. In any case, the lack of 
differences in attention and concentration safely excludes that improved memory formation 
for objects encoded during stress was due to a non-specific attention function after 
melatonin.  
Melatonin did not influence basal levels of cortisol, epinephrine and 
norepinephrine, which is in accordance with the majority of previous findings in healthy 
humans (Arangino et al. 1999; Cagnacci et al. 1998; Cagnacci et al. 1995; Forsling et al. 
1999; Nishiyama et al. 2001; Pawlikowski et al. 2002; Seabra et al. 2000; Waldhauser et al. 
1987; Wright et al. 1986). Furthermore, melatonin did not affect hormonal reactivity to 
stress. This finding is consistent with studies that failed to reveal dampening effects of 
melatonin in men or rats on the glucocorticoid response to an emotional stressor or 
hypoglycaemia-induced HPA activation within 90 minutes after exposure to these stimuli 
(Konakchieva et al. 1998; Perras et al. 2005). While we did not find changes in basal 
norepinephrine levels 60 min after melatonin intake, other investigators observed lower 
norepinephrine levels in melatonin-treated young men when measured in a supine position 
but not in an upright position (Arangino et al. 1999; Nishiyama et al. 2001). Indeed, a 
particular sensitivity of orthostatic sympathetic regulation to the effects of melatonin is 
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suggested as decreased norepinephrine levels in melatonin-treated subjects normalized after 
standing up for at least 15 min (Arangino et al. 1999; Nishiyama et al. 2001). Since our 
subjects were sitting during evaluation of baseline conditions, differences in body position 
may account for the observed discrepancy. 
The neurophysiological mechanisms mediating the enhancing effect of melatonin 
on memory formation are elusive. Since no melatonin-induced changes in stress hormone 
levels were observed, our findings are unlikely to be mediated by cortisol, epinephrine or 
norepinephrine. We offer two explanations potentially underlying the effect of melatonin 
on memory encoding. First, melatonin binding sites exist in various brain structures 
involved in memory function such as the hippocampus and prefrontal cortex (Brzezinski 
1997; Ekmekcioglu 2006; Mazzucchelli et al. 1996; Savaskan et al. 2005; Savaskan et al. 
2001). Under non-stress conditions, melatonin reduced rather than improved induction of 
long term potentiation (LTP) in hippocampal slices from mice, i.e., a synaptic plastic 
process believed to underlie the encoding of novels stimuli (Ozcan et al. 2006; Wang et al. 
2005). Moreover, a recent study in zebrafish describes a suppressive effect of 
administration of a very high melatonin dose on nighttime memory formation under non-
stress conditions (Rawashdeh et al. 2007). However, it is unknown whether these animal 
findings apply to daytime memory formation under resting conditions in humans. 
It is presently not known, but conceivable that stress conditions as investigated in 
the present study promote the release of neuromodulators (e.g., norepinephrine) that are 
able to shift the effect of melatonin on LTP induction into an opposite direction. Second, 
considering that melatonin is a potent sleep inducing factor (Wright et al. 1986) and sleep 
is known to enhance consolidation of hippocampus-dependent memories (Jern et al. 1991; 
Rasch et al. 2007), it is possible that 'sleep-like' melatonin effects on consolidation in the 
aftermath of encoding added to its effects on encoding. Indeed, since melatonin in the used 
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dose is known to degrade to baseline levels in four to eight hours after oral ingestion 
(Brzezinski 1997), it is likely that melatonin also influenced early processes of memory 
consolidation in our study. However, this rationale implies a similar effect of melatonin 
also under basal resting conditions not investigated here, which limits the interpretation of 
our data.  
In summary, our data indicate that melatonin rather than dampening hormonal 
responses to a social stressor exerts a genuinely central nervous effect by enhancing 
encoding of objects under stress, and possibly memory consolidation. Strength and 
specificity of this effect call for investigating whether this effect emerges selectively during 
stress conditions or likewise during rest. 
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Figure Legends 
 
Figure 1 
Overview of the experimental sessions. Learning of words took place on day 1. On day 2, 
subjects were administered melatonin or placebo and underwent the psychosocial stress test 
(TSST). During the TSST, subjects encoded memory for objects. After the TSST, subjects 
retrieved the words learnt on day 1. On day 3, retrieval of objects learnt during stress took 
place. 
 
Figure 2 (Panels A-B) 
Values are means±SEM. Across all subjects, the Trier Social Stress Test (large shaded area)  
elicited a significant response in stress hormone levels (Panels A-C). The TSST combines a 
short introduction phase followed by a 5-min preparation phase, a 5-min mock job interview, 
and a 5-min mental arithmetic task in front of an unknown panel of one man and one woman. 
The melatonin and the placebo group did not differ in hormonal reactivity to the TSST (all 
p’s > 0.14). 
 
Figure 3  
Values are means ± SEM. Melatonin compared to placebo, improved  recognition memory 
for the objects encoded during the Trier Social Stress Test stress. Melatonin enhanced 
memory accuracy (hit rate minus fals alarm rate). This effect was due to a higher hit rate 
for object recognition in the melatonin group. False alarm rate and response biases did not 
differ between groups.
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Table 1. Group characteristics of melatonin (MEL) and placebo (PL) group 
 Melatonin (3mg)  
(N= 27) 
Placebo  
(N=23) 
P 
Age [years] 24.41 ± 0.70 25.70 ± 0.93 .267 
Body Mass Index [kg/m²] 23.01 ± 0.51 23.17 ± 0.50 .826 
Heart rate (day 1) [beats/min]  70.48 ± 2.23 64.95± 2.57 .110 
MAP (day 1) [mmHg]  94.65 ± 1.65 93.98± 2.10 .800 
Attention (D2) (-65min) [score] 504.85 ± 13.41 486.39 ± 15.49 .370 
Wakefulness (MDBF) (-80 min) [score] 16.08 ± 0.54 15.22 ± 0.55 .274 
State anxiety (STAI) (-85min) [score] 36.88 ± 1.90 35.36 ± 1.71 .560 
Hit rate immediate recall (day 1) [score]  0.62 ± 0.03 0.63 ± 0.02 .730 
False alarm rate immediate recall (day 1) 
[score] 
0.59 ± 0.15 0.52 ± 0.17 .755 
Values given are mean ± SEM; MAP, mean arterial blood pressure, calculated as 2/3 DBP 
+ 1/3 SBP; hit rate, proportion of old objects classified as “old”; false alarm rate, 
proportion of new objects classified as “old”. 
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Figure 1 
Day 1 Day 2 Day 3
Encoding of Words
HR / BP measurement
Free Recall of Words
Melatonin / Placebo
TSST / Encoding of Objects
Free recall / Recognition of 
Words from Day 1
60 min
15 min Free Recall / Recognition
of Objects from Day 2
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Figure 2 
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